6Van der Gaag M, Stant DA, Wolters KJ, et al. Cognitive - behavioural therapy for persistent and recurrent psychosis in people with schizophrenia-spectrum disorder: cost-effectiveness analysis[J]. The British Journal of Psychiatry, 2011, 198 ( 1 ) : 59-65.
7American Psychiatric Association. Diagnostic and statistical manual of mental disorders[M]. 4th edi. Washington DC: Am eriean Psychiatric Association, 1994: 706-708.
8Robert A, Rosenheck, Michael J, et al. Developing A policy for second- generation antipsychotic drug[J]. Health Affairs,2009,28 ( 5 ) : 782-793.
9Davies LM, Lewis S, Jones PB, et al. Cost-effectiveness of first- v. second- generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy[J]. Br J Psychiatry, 2007, 191 (8): 14-22.
10Malla AK, Norman RM, Joober R. First-episode psychosis, early intervention, and outcome : what have we learned? [J]. Can J Psychiatry, 2006,51 ( 3 ) : 130.
